AA
PRNB

ALPS Advisors’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

ALPS Advisors’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-45,076
Closed -$2.69M – 968
2020
Q2 		$2.69M Sell
45,076
-14,532
-24% -$898K 0.04% 202
2020
Q1 		$3.54M Sell
59,608
-6,350
-10% -$370K 0.05% 170
2019
Q4 		$3.61M Buy
65,958
+18,192
+38% +$679K 0.03% 184
2019
Q3 		$1.35M Sell
47,766
-2,184
-4% -$80.1K 0.01% 256
2019
Q2 		$1.66M Buy
+49,950
New +$1.56M 0.01% 253

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

ALPS Advisors's PRNB Position: Q3 2020 in Review

ALPS Advisors sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 45,076 shares — an estimated $2.69M sold.

ALPS Advisors first reported a position in PRNB in Q2 2019 and held it in 5 quarters. The position peaked at $3.61M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • ALPS Advisors reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • ALPS Advisors sold 45,076 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.69M.
  • ALPS Advisors first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • ALPS Advisors's Principia Biopharma Inc. Common Stock position peaked at $3.61M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on ALPS Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.